https://www.selleckchem.com/pr....oducts/epacadostat-i
001). Hyperlipidemia also reduced risk of mortality. However, age, diabetes, renal disease, chronic obstructive pulmonary disease, cerebrovascular disease, and dementia were significant risk factors for mortality. In the subgroup analysis, the risk of mortality decreased most substantially in those aged 70 years (HR 0.45, 95% CI 0.28-0.72). Immunosuppressant use was associated with a 22% reduced risk of BP mortality. The effects were more substantial in those aged 70 years, with a 55% reduced risk of mortality. Im
Like
Comment
Share
